Email to SPL investor relations, page-27

Hi guys, I have waited since the 8th of this month and still have not received a reply.....

I have just sent the updated email below to investor relations........ I DO NOT EXPECT A REPLY

Hello,

Iam a long term investor in SPL and I have been growing more and more frustratedof late with the lack of news coming out of SPL.

Canyou please provide comment on the following questions I have Re: VIRALEZE:

1. Where is the updates on regulatory approval progress in other regions / countries?
   1. India approvals have been received
2. Where is the marketing for EU?
   1. The website is NOT ENOUGH. I have friends across EU that have never heard of VIRALEZE…… Why not?
3. Where is the licence deals for EU?
   1. Still waiting on these…….
4. Where is the updates on sales to date?
   1. If you had any interest in maintaining SP value, you would release an update to market Re: sales to date with Lloyds. With the latest suspension of sales in UK, surely you would be able to regain a little investor confidence by telling us how much product has been sold…….
5. Where are these partnership deals we hear about with sporting teams and airlines etc?
   1. You really need to start executing some of these partnerships you have been listing in announcements. If there is no partnership for Olympics, then SPL has failed.
6. Where are the results from the Perth Trial?
   1. Still waiting on these results.

The deafening silence from SPL to the markethas caused the SP to tank by close to ~36% over the past 4 months.

Can you please also provide some clarity onwhat the recent CR funds are being used for? In the leadup to the CR it wassaid that funds would be used to expedite the current Ph2 DEP trials….. Againthere has been absolute silence on this front from SPL.

Surely a VERY SMALL investment in marketingwould be beneficial to help stem the bleeding. SPL is now a pharma company withproducts on sale, it is time to evolve from the research lab and develop into arevenue generating pharma.

Kind regards,